Histidine
- Generic Name
- Histidine
- Brand Names
- Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C6H9N3O2
- CAS Number
- 71-00-1
- Unique Ingredient Identifier
- 4QD397987E
- Background
An essential amino acid that is required for the production of histamine.
- Indication
The actions of supplemental L-histidine are entirely unclear. It may have some immunomodulatory as well as antioxidant activity. L-histidine may be indicated for use in some with rheumatoid arthritis. It is not indicated for treatment of anemia or uremia or for lowering serum cholesterol.
- Associated Conditions
- -
- Associated Therapies
- Amino acid supplementation
Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease
- First Posted Date
- 2023-12-14
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 200
- Registration Number
- NCT06169826
- Locations
- 🇺🇸
Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States
Histaminergic Basis of Fatigue in Multiple Sclerosis
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2021-07-29
- Lead Sponsor
- University of Miami
- Registration Number
- NCT04764383
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath